PARP Inhibitors in Reproductive System Cancers: Current Use and Developments

por O’Sullivan Coyne, Geraldine, Chen, Alice P., Meehan, Robert, Doroshow, James H.
Publicado 2017

Impact of age on antigen-specific T lymphocyte response in patients treated with PSA-TRICOM

por Singh, Harpreet, Madan, Ravi, Marte, Jennifer, O'Sullivan-Coyne, Geraldine, Steinberg, Seth, Heery, Christopher, Schlom, Jeffrey, Gulley, James
Publicado 2014

PARP Inhibitor Applicability: Detailed Assays for Homologous Recombination Repair Pathway Components

por O’Sullivan Coyne, Geraldine, Karlovich, Chris, Wilsker, Deborah, Voth, Andrea Regier, Parchment, Ralph E, Chen, Alice P, Doroshow, James H
Publicado 2022

A Phase I Study of Ganetespib and Ziv‐Aflibercept in Patients with Advanced Carcinomas and Sarcomas

por Meehan, Robert, Kummar, Shivaani, Do, Khanh, O'Sullivan Coyne, Geraldine, Juwara, Lamin, Zlott, Jennifer, Rubinstein, Larry, Doroshow, James H., Chen, Alice P.
Publicado 2018

Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma

por Nguyen, James, Takebe, Naoko, Kummar, Shivaani, Razak, Albiruni, Chawla, Sant P., George, Suzanne, Patel, Shreyaskumar R., Keohan, Mary Louise, Movva, Sujana, O'Sullivan Coyne, Geraldine, Do, Khanh, Juwara, Lamin, Augustine, Brooke, Steinberg, Seth M., Kuhlmann, Laura, Ivy, S. Percy, Doroshow, James H., Chen, Alice P.
Publicado 2023

Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas

por O'Sullivan Coyne, Geraldine, Kummar, Shivaani, Hu, James, Ganjoo, Kristen, Chow, Warren A., Do, Khanh T., Zlott, Jennifer, Bruns, Ashley, Rubinstein, Lawrence, Foster, Jared C., Juwara, Lamin, Meehan, Robert, Piekarz, Richard, Streicher, Howard, Sharon, Elad, Takebe, Naoko, Voth, Andrea Regier, Bottaro, Donald, Costello, Rene, Wright, John J., Doroshow, James H., Chen, Alice P.
Publicado 2022

Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma

por Rajan, Arun, Heery, Christopher R., Thomas, Anish, Mammen, Andrew L., Perry, Susan, O’Sullivan Coyne, Geraldine, Guha, Udayan, Berman, Arlene, Szabo, Eva, Madan, Ravi A., Ballester, Leomar Y., Pittaluga, Stefania, Donahue, Renee N., Tsai, Yo-Ting, Lepone, Lauren M., Chin, Kevin, Ginty, Fiona, Sood, Anup, Hewitt, Stephen M., Schlom, Jeffrey, Hassan, Raffit, Gulley, James L.
Publicado 2019

A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction

por Takebe, Naoko, Beumer, Jan H., Kummar, Shivaani, Kiesel, Brian F., Dowlati, Afshin, O'Sullivan Coyne, Geraldine, Piekarz, Richard, Rubinstein, Lawrence, Fogli, Laura K., Vaishampayan, Ulka, Goel, Sanjay, O'Bryant, Cindy L., El‐Rayes, Bassel F., Chung, Vincent, Lenz, Heinz‐Josef, Kim, Richard, Belani, Chandra P., Tuscano, Joseph M., Schelman, William, Moore, Nancy, Doroshow, James H., Chen, Alice P.
Publicado 2019

Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II Trial

por Chen, Alice P., Kummar, Shivaani, Moore, Nancy, Rubinstein, Lawrence V., Zhao, Yingdong, Williams, P. Mickey, Palmisano, Alida, Sims, David, O'Sullivan Coyne, Geraldine, Rosenberger, Christina L., Simpson, Mel, Raghav, Kanwal P. S., Meric-Bernstam, Funda, Leong, Stephen, Waqar, Saiama, Foster, Jared C., Konaté, Mariam M., Das, Biswajit, Karlovich, Chris, Lih, Chih-Jian, Polley, Eric, Simon, Richard, Li, Ming-Chung, Piekarz, Richard, Doroshow, James H.
Publicado 2021